Early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography

Yano, Hideki; Horinaka, Shigeo; Ishikawa, Mayuko; Ishimitsu, Toshihiko

doi:10.1007/s00380-016-0940-9

Cited by 11 publications

(8 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 In addition, a recent study, in which one-third of the subjects underwent CoCr-EES implantation for ACS, showed resolution of most of the uncovered struts at 3-month follow-up (0.4-6.9%). 18, 19 Because a previous pathological study has shown that rate of >30% of uncovered struts is one of the best morphologic predictor of late ST, 20 our present study results strongly support the safety of CoCr-EES for use in STEMI lesions.…”

Section: Discussionsupporting

confidence: 72%

Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt–Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease

Ishida

Terashita

Itoh

et al. 2020

Circ J

View full text Add to dashboard Cite

occurs within 3 months after DES implantation in AMI patients and that delayed vessel healing at the thrombotic lesion is observed within 30 days after DES implantation. 1,3-6 Thus, rapid progression of vascular healing during the early phase, together with thromboresistance, is the desired outcome of DES for AMI patients.Cobalt-chromium everolimus-eluting stent (CoCr-EES), Stent thrombosis (ST) rarely occurs in patients undergoing 2nd-generation drug-eluting stent (DES) implantation for coronary artery disease (CAD), although it remains a critical complication. 1 Patients with acute myocardial infarction (AMI) especially have a relatively high incidence of ST as compared with stable CAD patients. 2 It has also been demonstrated that ST mainly

show abstract

Section: Discussionsupporting

confidence: 72%

Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt–Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease

Ishida

Terashita

Itoh

et al. 2020

Circ J

View full text Add to dashboard Cite

show abstract

“…As expected, the healing speed after DES + DCB seemed to be slower than that after DES alone [ 3 ]. In such cases, the duration of dual antiplatelet therapy (DAPT) should not be shorter than the duration recommended in the current guidelines although there is a trend regarding the shortening of the duration of DAPT after current-generation DES implantation [ 4 , 5 ].…”

supporting

confidence: 65%

Angioscopic imaging one month after the implantation of a drug-eluting stent following drug-coated balloon treatment

Sone

Mori

Sato

et al. 2018

IJC Heart & Vasculature

View full text Add to dashboard Cite

“…17,18) Moreover, an OCT study evaluating early EES responses showed that the malapposition of stent struts completely disappeared at four weeks after stent implantation, and almost all neointimal coverage of stent struts was achieved within 12 weeks. 19) A meta-analysis of DES evaluated the overall best combination of healing with suppression of neointimal hyperplasia at 6-12 months, 20) which displayed that EES performed better results than any other types of DES. A recent study assessing the BP-EES strut response for acute coronary syndrome lesions reported that BP-EES resulted in an earlier neointimal coverage than conventional DP-EES.…”

Section: Discussionmentioning

confidence: 99%

Comparison of Neointimal Response between Durable-Polymer Everolimus-Eluting Stent and Bioabsorbable-Polymer Everolimus-Eluting Stent for Severely Calcified Lesions Requiring Rotational Atherectomy

et al. 2020

View full text Add to dashboard Cite

Clinical outcomes after percutaneous coronary intervention (PCI) for severely calcified lesions remain poor. The purpose of this study was to investigate the neointimal response after everolimus-eluting stents (EES) for severely calcified lesions treated with rotational atherectomy (RA) using optical coherence tomography (OCT).We retrospectively analyzed 34 lesions in which PCI was performed with EES deployment following RA and OCT was performed immediately after PCI and at follow-up (nine months). The EES was either durablepolymer (DP) EES (22 lesions) or bioabsorbable polymer (BP)-EES (12 lesions). Strut coverage and malapposition were evaluated at 1-mm intervals of cross-section (CS) by serial OCT analysis. Malapposed strut was defined as having the distance from luminal border > 100 μm.A total of 11,823 struts immediately after PCI and 11,720 struts at follow-up were analyzed. Immediately after PCI, the strut-level analysis showed no significant differences in the percentage of malapposed struts between the DP-EES group and the BP-EES group. At follow-up, the BP-EES group showed a more prevalent covered strut compared with the DP-EES group (strut-level analysis: 95% versus 97%, P = 0.045; CS-level analysis: 97% versus 100%, P < 0.01; lesion-level analysis: 27% versus 83%, P < 0.01, respectively).In severely calcified lesions requiring RA, the BP-EES group achieved better neointimal coverage than the DP-EES group at nine months. Additional prospective studies are needed.

show abstract

Early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography

Cited by 11 publications

References 34 publications

Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt–Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease

Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt–Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease

Angioscopic imaging one month after the implantation of a drug-eluting stent following drug-coated balloon treatment

Comparison of Neointimal Response between Durable-Polymer Everolimus-Eluting Stent and Bioabsorbable-Polymer Everolimus-Eluting Stent for Severely Calcified Lesions Requiring Rotational Atherectomy

Contact Info

Product

Resources

About